sunitynib mylan 37,5 mg kapsułki twarde
mylan ireland limited - sunitinibum - kapsułki twarde - 37,5 mg
sunitynib mylan 50 mg kapsułki twarde
mylan ireland limited - sunitinibum - kapsułki twarde - 50 mg
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - Środki przeciwnowotworowe - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
asikreba 37,5 mg kapsułki twarde
zentiva, k.s. - sunitinib malate - kapsułki twarde - 37,5 mg
asikreba 50 mg kapsułki twarde
zentiva, k.s. - sunitynibu jabłaczan - kapsułki twarde - 50 mg
asikreba 25 mg kapsułki twarde
zentiva, k.s. - sunitinib malate - kapsułki twarde - 25 mg
asikreba 12,5 mg kapsułki twarde
zentiva, k.s. - sunitinib malate - kapsułki twarde - 12,5 mg
sunitinib g.l. pharma 25 mg kapsułki twarde
g.l. pharma gmbh - sunitinibum - kapsułki twarde - 25 mg
sunitinib g.l. pharma 50 mg kapsułki twarde
g.l. pharma gmbh - sunitinibum - kapsułki twarde - 50 mg
sunitinib g.l. pharma 12,5 mg kapsułki twarde
g.l. pharma gmbh - sunitinibum - kapsułki twarde - 12,5 mg